Showing results (3111-3120 of 6,740) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|March 21, 2014
Clinical effectiveness, toxicity, and failure patterns of helical tomotherapy for postoperative oral cavity cancer patientsChen-Hsi Hsieh, Pei-Wei Shueng, Li-Ying Wang, et al.
Oncotargets and Therapy|February 10, 2017
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester diseaseZsófia Váradi, Rita Bánusz, Judit Csomor, et al.
Oncotargets and Therapy|February 9, 2017
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance statusNobuhiro Hata, Koji Yoshimoto, Ryusuke Hatae, et al.
Oncotargets and Therapy|February 1, 2017
Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms' tumorFengyin Sun, Wenyi Li, Lie Wang, et al.
Oncotargets and Therapy|February 1, 2017
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysisSongcheng Yin, Zhan Li, Jinyu Huang, et al.
Oncotargets and Therapy|February 1, 2017
Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing miceZhaoshuo Yang, Jianhua Liu, Qingqing Huang, et al.
Oncotargets and Therapy|February 1, 2017
Chidamide in the treatment of peripheral T-cell lymphomaThomas S Chan, Eric Tse, Yok-Lam Kwong
Oncotargets and Therapy|January 6, 2017
Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological studyYuping Wang, Fanling Meng, Yunduo Liu, et al.
Oncotargets and Therapy|January 6, 2017
Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trialsXiaoping Liu, Jiarui Chen, Yuncen A He, et al.
Oncotargets and Therapy|January 6, 2017
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphomaQunling Zhang, Junning Cao, Kai Xue, et al.
Pageof 674